An emerging treatment for clinical depression has reached an important milestone. This week, the Food and Drug Administration ...

The announcement was welcome news for those with major depressive disorder, affecting an estimated 8.3% of the adult ...

Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the ...

The U.S. Food and Drug Administration expanded approval for Johnson & Johnson's nasal spray, Spravato, to allow it to be used ...

Johnson & Johnson's ketamine-derived nasal spray has been approved as a standalone treatment to fight depression for those ...

The U.S. Food and Drug Administration approved Johnson & Johnson's ketamine-based nasal spray Spravato to treat adults with ...

Effective treatments for people with serious depression who have not been helped by antidepressant medications have novel ...

Ketamine, the controlled drug best known as a horse tranquilizer or party supplement, has in the last four years become a ...

The Food and Drug Administration (FDA) has approved Spravato, a nasal spray developed by Johnson & Johnson, as a standalone ...

Respondents who said they used other drugs recreationally were also likelier to say they used ketamine during the past year ...

The following is a summary of “Intranasal racemic ketamine maintenance therapy for patients with treatment-resistant ...